Dr. John Branda, MD

NPI: 1104809573
Total Payments
$67,847
2022 Payments
$103.71
Companies
4
Transactions
22

Payment Breakdown by Category

Consulting$62,750 (92.5%)
Travel$2,062 (3.0%)
Research$2,000 (2.9%)
Food & Beverage$1,035 (1.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $62,750 5 92.5%
Travel and Lodging $2,062 8 3.0%
Unspecified $2,000 1 2.9%
Food and Beverage $1,035 8 1.5%

Payments by Type

General
$65,847
21 transactions
Research
$2,000
1 transactions

Top Paying Companies

Company Total Records Latest Year
DiaSorin Inc. $34,666 9 $0 (2019)
T2 Biosystems, Inc. $28,500 3 $0 (2019)
Roche Diagnostics Corporation $4,578 9 $0 (2019)
PFIZER INTERNATIONAL LLC $103.71 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $103.71 1 PFIZER INTERNATIONAL LLC ($103.71)
2019 $25,243 18 DiaSorin Inc. ($18,666)
2018 $27,000 2 DiaSorin Inc. ($16,000)
2017 $15,500 1 T2 Biosystems, Inc. ($15,500)

All Payment Transactions

22 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/07/2022 PFIZER INTERNATIONAL LLC Food and Beverage In-kind items and services $103.71 General
06/28/2019 DiaSorin Inc. Travel and Lodging In-kind items and services $68.47 General
Category: Lyme
06/28/2019 DiaSorin Inc. Travel and Lodging In-kind items and services $47.23 General
Category: Lyme
06/28/2019 DiaSorin Inc. Food and Beverage In-kind items and services $32.09 General
Category: Lyme
06/27/2019 DiaSorin Inc. Travel and Lodging In-kind items and services $395.92 General
Category: Lyme
06/27/2019 DiaSorin Inc. Travel and Lodging In-kind items and services $168.59 General
Category: Lyme
06/27/2019 DiaSorin Inc. Food and Beverage In-kind items and services $108.40 General
Category: Lyme
06/27/2019 DiaSorin Inc. Travel and Lodging In-kind items and services $95.10 General
Category: Lyme
06/01/2019 T2 Biosystems, Inc. T2Dx (Device) Cash or cash equivalent $2,000.00 Research
Study: T2Lyme • Category: Molecular Diagnostic Instrument
03/26/2019 Roche Diagnostics Corporation MD Research and Development (Device) Travel and Lodging In-kind items and services $562.74 General
Category: Molecular Diagnostics
03/26/2019 Roche Diagnostics Corporation MD Research and Development (Device) Food and Beverage In-kind items and services $281.79 General
Category: Molecular Diagnostics
03/26/2019 Roche Diagnostics Corporation MD Research and Development (Device) Food and Beverage In-kind items and services $222.41 General
Category: Molecular Diagnostics
03/26/2019 Roche Diagnostics Corporation MD Research and Development (Device) Food and Beverage In-kind items and services $163.32 General
Category: Molecular Diagnostics
03/19/2019 Roche Diagnostics Corporation CD cobas Analyzer Series (Device) Consulting Fee Cash or cash equivalent $2,500.00 General
Category: Centralized Diagnostics
03/15/2019 Roche Diagnostics Corporation MD Research and Development (Device) Travel and Lodging Cash or cash equivalent $132.77 General
Category: Molecular Diagnostics
03/07/2019 Roche Diagnostics Corporation MD Research and Development (Device) Food and Beverage In-kind items and services $105.96 General
Category: Molecular Diagnostics
03/06/2019 Roche Diagnostics Corporation MD Research and Development (Device) Travel and Lodging Cash or cash equivalent $591.67 General
Category: Molecular Diagnostics
02/25/2019 Roche Diagnostics Corporation MD Research and Development (Device) Food and Beverage In-kind items and services $17.02 General
Category: Molecular Diagnostics
01/10/2019 DiaSorin Inc. Consulting Fee Cash or cash equivalent $17,750.00 General
Category: More than 5 specific products
12/21/2018 T2 Biosystems, Inc. Consulting Fee Cash or cash equivalent $11,000.00 General
05/17/2018 DiaSorin Inc. Consulting Fee Cash or cash equivalent $16,000.00 General
Category: IVD
09/01/2017 T2 Biosystems, Inc. T2Dx (Device) Consulting Fee Cash or cash equivalent $15,500.00 General
Category: Molecular Diagnostic Instrument

Research Studies & Clinical Trials

Study Name Company Amount Records
T2Lyme T2 Biosystems, Inc. $2,000 1

About Dr. John Branda, MD

Dr. John Branda, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1104809573.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Branda, MD has received a total of $67,847 in payments from pharmaceutical and medical device companies, with $103.71 received in 2022. These payments were reported across 22 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($62,750).

Practice Information

Products in Payments

  • T2Dx (Device) $17,500
  • CD cobas Analyzer Series (Device) $2,500
  • MD Research and Development (Device) $2,078

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in Boston